BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 18522674)

  • 1. Effects of chronic celecoxib on testicular function in normal and lipopolysaccharide-treated rats.
    Winnall WR; Muir JA; Liew S; Hirst JJ; Meachem SJ; Hedger MP
    Int J Androl; 2009 Oct; 32(5):542-55. PubMed ID: 18522674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons.
    Huang Y; Liu J; Wang LZ; Zhang WY; Zhu XZ
    Acta Pharmacol Sin; 2005 Aug; 26(8):952-8. PubMed ID: 16038627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cyclooxygenase 2 genetic variant -765G>C does not modulate the effects of celecoxib on prostaglandin E2 production.
    Skarke C; Reus M; Schmidt R; Grundei I; Schuss P; Geisslinger G; Lötsch J
    Clin Pharmacol Ther; 2006 Dec; 80(6):621-32. PubMed ID: 17178263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive expression of prostaglandin-endoperoxide synthase 2 by somatic and spermatogenic cells is responsible for prostaglandin E2 production in the adult rat testis.
    Winnall WR; Ali U; O'Bryan MK; Hirst JJ; Whiley PA; Muir JA; Hedger MP
    Biol Reprod; 2007 May; 76(5):759-68. PubMed ID: 17251525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
    Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors.
    Ferrario A; Fisher AM; Rucker N; Gomer CJ
    Cancer Res; 2005 Oct; 65(20):9473-8. PubMed ID: 16230411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain.
    Guo JY; Li CY; Ruan YP; Sun M; Qi XL; Zhao BS; Luo F
    Eur J Pharmacol; 2009 Jun; 612(1-3):54-60. PubMed ID: 19356723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsteroidal anti-inflammatory drugs increase expression of inducible COX-2 isoform of cyclooxygenase in spinal cord of rats with adjuvant induced inflammation.
    Hsueh SF; Lu CY; Chao CS; Tan PH; Huang YW; Hsieh SW; Hsiao HT; Chung NC; Lin SH; Huang PL; Lyu PC; Yang LC
    Brain Res Mol Brain Res; 2004 Jun; 125(1-2):113-9. PubMed ID: 15193428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic anti-hyperalgesia of electroacupuncture and low dose of celecoxib in monoarthritic rats: involvement of the cyclooxygenase activity in the spinal cord.
    Mi WL; Mao-Ying QL; Liu Q; Wang XW; Wang YQ; Wu GC
    Brain Res Bull; 2008 Sep; 77(2-3):98-104. PubMed ID: 18721668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of cyclooxygenase-2 in the potentiation of allyl alcohol-induced liver injury by bacterial lipopolysaccharide.
    Ganey PE; Barton YW; Kinser S; Sneed RA; Barton CC; Roth RA
    Toxicol Appl Pharmacol; 2001 Jul; 174(2):113-21. PubMed ID: 11446826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of 2 celecoxib derivatives: analgesic effect and selectivity to cyclooxygenase-2/1.
    Lu ZH; Xiong XY; Zhang BL; Lin GC; Shi YX; Liu ZG; Meng JR; Zhou YM; Mei QB
    Acta Pharmacol Sin; 2005 Dec; 26(12):1505-11. PubMed ID: 16297351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR1 and CCR5 chemokine receptors are involved in fever induced by LPS (E. coli) and RANTES in rats.
    Machado RR; Soares DM; Proudfoot AE; Souza GE
    Brain Res; 2007 Aug; 1161():21-31. PubMed ID: 17604006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
    Ohneseit PA; Krebiehl G; Dittmann K; Kehlbach R; Rodemann HP
    Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation.
    Wallace JL; Zamuner SR; McKnight W; Dicay M; Mencarelli A; del Soldato P; Fiorucci S
    Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G76-81. PubMed ID: 14665439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The response of testicular leukocytes to lipopolysaccharide-induced inflammation: further evidence for heterogeneity of the testicular macrophage population.
    Gerdprasert O; O'Bryan MK; Muir JA; Caldwell AM; Schlatt S; de Kretser DM; Hedger MP
    Cell Tissue Res; 2002 May; 308(2):277-85. PubMed ID: 12037584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of pulmonary leukotriene B4 production by cyclooxygenase-2 inhibitors and lipopolysaccharide.
    Mao JT; Tsu IH; Dubinett SM; Adams B; Sarafian T; Baratelli F; Roth MD; Serio KJ
    Clin Cancer Res; 2004 Oct; 10(20):6872-8. PubMed ID: 15501964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celecoxib modulates the capacity for prostaglandin E2 and interleukin-10 production in alveolar macrophages from active smokers.
    Mao JT; Roth MD; Serio KJ; Baratelli F; Zhu L; Holmes EC; Strieter RM; Dubinett SM
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5835-41. PubMed ID: 14676104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of cyclooxygenase-2 in rat models of conjunctivitis.
    Oka T; Shearer T; Azuma M
    Curr Eye Res; 2004 Jul; 29(1):27-34. PubMed ID: 15370364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide (NO)-releasing naproxen (HCT-3012 [(S)-6-methoxy-alpha-methyl-2-naphthaleneacetic Acid 4-(nitrooxy)butyl ester]) interactions with aspirin in gastric mucosa of arthritic rats reveal a role for aspirin-triggered lipoxin, prostaglandins, and NO in gastric protection.
    Fiorucci S; Di Lorenzo A; Renga B; Farneti S; Morelli A; Cirino G
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1264-71. PubMed ID: 15297470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis.
    Abou-Issa HM; Alshafie GA; Seibert K; Koki AT; Masferrer JL; Harris RE
    Anticancer Res; 2001; 21(5):3425-32. PubMed ID: 11848504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.